Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1991-2-27
|
pubmed:abstractText |
In a controlled trial comparing acyclovir with vidarabine in the treatment of neonatal herpes simplex virus (HSV) infection, we found no significant difference between the treatments in adjusted mortality and morbidity. Hence, we sought to define for the entire cohort (n = 202) the clinical characteristics that best predicted the eventual outcome in these neonates.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0028-4793
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
14
|
pubmed:volume |
324
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
450-4
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:1988830-Consciousness,
pubmed-meshheading:1988830-Disseminated Intravascular Coagulation,
pubmed-meshheading:1988830-Encephalitis,
pubmed-meshheading:1988830-Herpes Simplex,
pubmed-meshheading:1988830-Humans,
pubmed-meshheading:1988830-Infant, Newborn,
pubmed-meshheading:1988830-Multivariate Analysis,
pubmed-meshheading:1988830-Prospective Studies,
pubmed-meshheading:1988830-Seizures,
pubmed-meshheading:1988830-Survival Analysis
|
pubmed:year |
1991
|
pubmed:articleTitle |
Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.
|
pubmed:affiliation |
Department of Pediatrics, University of Alabama, Birmingham.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|